Keurig Dr Pepper Inc. · KDP · FY2025 Q2 · Calendar Q3 2025
KDP: Refreshment growth offsets coffee and cost pressures
The quarter supports a mixed operating picture: strong refreshment and energy momentum, product launches, and distribution expansion provide growth support, while coffee softness, input costs, tariffs, and acquisition reliance temper the durability of that trajectory.
Earnings scorecard
Reported versus consensusMarket reaction
prior-close to event-session closeAsk FN2 about KDP FY2025 Q2
Transcript, numbers and history already loadedFree account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The current analysis highlights stronger refreshment-beverage momentum and several product and distribution initiatives, alongside a more subdued back-half outlook for coffee because of commodity inflation and tariffs.
Guidance delta
Management maintained 2025 full-year guidance, targeting mid-single-digit sales growth and high-single-digit EPS growth.
Key takeaways
- Management described 7% constant-currency net sales growth and double-digit EPS growth in Q2.
- U.S. refreshment beverages grew about 10.5%, led by energy, sports hydration, and innovation.
- Coffee is expected to be subdued in the back half as commodity inflation and tariffs weigh.
- The growth plan combines new products, energy brands, DSD expansion, and acquisitions.
Management priorities
- Expand the DSD network in California, Nevada, and the Midwest.
- Launch Bloom pop, new Lavazza K-Cup varieties, and additional brewer products.
- Build the energy portfolio and use digital marketing and consumer data to improve targeting.
Follow KDP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 8, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Argus Research | Buy | Buy | Maintain | Sep 15, 2026 |
| HSBC | Buy | Hold | Upgrade | Aug 13, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 10, 2026 |
| UBS | Buy | Buy | Maintain | Aug 7, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Aug 7, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 23, 2026 |
| Citigroup | Buy | Buy | Maintain | Jul 14, 2026 |
| BNP Paribas | Neutral | Underperform | Upgrade | Apr 22, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Apr 8, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 30, 2026 |
| Jefferies | Hold | Buy | Downgrade | Dec 17, 2025 |
| Piper Sandler | Overweight | Overweight | Maintain | Dec 15, 2025 |
| B of A Securities | Buy | Buy | Maintain | Oct 8, 2025 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 2, 2025 |
| RBC Capital | Outperform | Outperform | Maintain | Apr 22, 2025 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Apr 1, 2025 |
| TD Cowen | Hold | Hold | Maintain | Jan 8, 2025 |
| Truist Securities | Hold | Sell | Upgrade | Jun 17, 2024 |
| Wedbush | Outperform | Outperform | Maintain | Feb 26, 2024 |
| Bernstein | Outperform | Outperform | Maintain | Oct 12, 2023 |
| Credit Suisse | Neutral | Neutral | Maintain | Apr 30, 2021 |
| Bank of America | Buy | Buy | Maintain | Aug 9, 2019 |
| BMO Capital | Outperform | Market Perform | Upgrade | Jun 17, 2019 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Dec 7, 2018 |
| Macquarie | Outperform | Outperform | Maintain | Dec 4, 2018 |
| Gabelli & Co. | Hold | Buy | Downgrade | Nov 9, 2018 |
| Guggenheim | Neutral | Neutral | Maintain | Sep 14, 2018 |
| Susquehanna | Outperform | Positive | Maintain | Jul 25, 2018 |
| Stifel Nicolaus | Hold | Hold | Maintain | Jul 11, 2018 |
Named analyst price targets
Upside is calculated against the persisted current price $30.54. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Morgan Stanley | Dara Mohsenian | $38 | $31.06 | +24.4% | Aug 20, 2026 |
| HSBC | Analyst unavailable | $40 | $29.56 | +31.0% | Aug 13, 2026 |
| Barclays | Analyst unavailable | $38 | $30.01 | +24.4% | Aug 10, 2026 |
| RBC Capital | Nik Modi | $42 | $30.88 | +37.5% | Aug 4, 2026 |
| UBS | Peter Grom | $38 | $31.05 | +24.4% | Jul 16, 2026 |
| Bernstein | Analyst unavailable | $39 | $31.24 | +27.7% | Jul 8, 2026 |
| Wells Fargo | Analyst unavailable | $37 | $32.73 | +21.2% | Jul 1, 2026 |
| Bernstein | Analyst unavailable | $38 | $31.23 | +24.4% | Jun 11, 2026 |
| UBS | Analyst unavailable | $34 | $28.85 | +11.3% | Apr 24, 2026 |
| Evercore ISI | Analyst unavailable | $30 | $28.76 | -1.8% | Apr 24, 2026 |
| Barclays | Analyst unavailable | $28 | $25.93 | -8.3% | Apr 14, 2026 |
| UBS | Peter Grom | $36 | $30.49 | +17.9% | Feb 26, 2026 |
| Jefferies | Kaumil Gajrawala | $32 | $28.59 | +4.8% | Dec 16, 2025 |
| Piper Sandler | Michael Lavery | $38 | $29.5 | +24.4% | Dec 15, 2025 |
| Deutsche Bank | Analyst unavailable | $32 | $29.5 | +4.8% | Dec 15, 2025 |
| UBS | Peter Grom | $35 | $28.69 | +14.6% | Oct 28, 2025 |
| Barclays | Lauren Lieberman | $30 | $28.64 | -1.8% | Oct 28, 2025 |
| Wells Fargo | Analyst unavailable | $35 | $28.68 | +14.6% | Oct 28, 2025 |
| BNP Paribas | Kevin Grundy | $24 | $27.11 | -21.4% | Sep 22, 2025 |
| HSBC | Sorabh Daga | $30 | $30.48 | -1.8% | Aug 26, 2025 |
| Jefferies | Kaumil Gajrawala | $41 | $31.1 | +34.3% | Aug 25, 2025 |
| HSBC | Analyst unavailable | $42 | $34.4 | +37.5% | Apr 25, 2025 |
| Barclays | Analyst unavailable | $39 | $34.2 | +27.7% | Feb 27, 2025 |
| Piper Sandler | Mike Lavery | $35 | $34.12 | +14.6% | Feb 25, 2025 |
| Jefferies | Kaumil Gajrawala | $42 | $36.92 | +37.5% | Oct 16, 2024 |
| Barclays | Lauren Lieberman | $41 | $36.51 | +34.3% | Oct 11, 2024 |
| Deutsche Bank | Steve Powers | $37 | $37.46 | +21.2% | Sep 23, 2024 |
| Citigroup | Filippo Falorni | $43 | $37.46 | +40.8% | Sep 23, 2024 |
| Barclays | Lauren Lieberman | $37 | $33.14 | +21.2% | Jul 19, 2024 |
| Truist Financial | Bill Chappell | $34 | $34.06 | +11.3% | Jun 17, 2024 |
| UBS | Sean King | $40 | $34.22 | +31.0% | Jun 10, 2024 |
| Wells Fargo | Bonnie Herzog | $41 | $34.82 | +34.3% | Jun 5, 2024 |
| Jefferies | Kaumil Gajrawala | $39 | $33.84 | +27.7% | Apr 25, 2024 |
| Jefferies | Kaumil Gajrawala | $35 | $30.73 | +14.6% | Mar 27, 2024 |
| Credit Suisse | Theo Brito | $38 | $35 | +24.4% | Mar 21, 2023 |
| Wells Fargo | Analyst unavailable | $40 | $35.34 | +31.0% | Jan 3, 2023 |
| Deutsche Bank | Analyst unavailable | $39 | $37.76 | +27.7% | Dec 6, 2022 |
| Deutsche Bank | Steve Powers | $38 | $38.11 | +24.4% | Oct 28, 2022 |
| Goldman Sachs | Bonnie Herzog | $37 | $37.28 | +21.2% | Sep 27, 2022 |
| Barclays | Analyst unavailable | $46 | $37.8 | +50.6% | May 2, 2022 |
| RBC Capital | Analyst unavailable | $43 | $37.99 | +40.8% | Apr 29, 2022 |
| UBS | Sean King | $41 | $34.67 | +34.3% | Jul 30, 2021 |
| Morgan Stanley | Dara Mohsenian | $36 | $35.11 | +17.9% | Apr 30, 2021 |
Track every rating change on KDP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationKeurig Dr Pepper Inc. is a prominent beverage firm with operations spanning both the United States and global markets. The company structures its business across four primary divisions: Coffee Systems, Packaged Beverages, Beverage Concentrates, and Latin America Beverages. Its Coffee Systems division is responsible for the production and distribution of an array of finished products linked to its coffee brewing systems, including K-Cup single-serve pods, brewing machines, and specialized coffee blends. Brewers are offered for sale via external distributors, various retail outlets, and directly through its official website, keurig.com. The Packaged Beverages segment focuses on manufacturing and distributing its proprietary packaged drink labels.…
Historical context
All KDP earningsConsumer Defensive peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| STZ Constellation Brands, Inc. | FY2027 Q2 · Calendar Q4 2026 | +5.4% | +2.4% | Constellation Brands beats expectations and maintains FY27 EPS guidance |
| LW Lamb Weston Holdings, Inc. | FY2027 Q1 · Calendar Q4 2026 | +27.8% | +7.5% | Lamb Weston raises FY2027 outlook as North America volume growth continues |
| MKC McCormick & Company, Incorporated | FY2026 Q3 · Calendar Q4 2026 | +13.9% | -4.9% | McCormick reports strong Q3 growth while U.S. volumes remain soft |
| CAG Conagra Brands, Inc. | FY2027 Q1 · Calendar Q3 2026 | +44.4% | -4.9% | Conagra maintains outlook while increasing brand investment and simplifying SKUs |
| COST Costco Wholesale Corporation | FY2026 Q4 · Calendar Q3 2026 | +3.2% | +2.9% | Costco’s growth broadens as warehouses and digital sales accelerate |
| GIS General Mills, Inc. | FY2027 Q1 · Calendar Q3 2026 | +4.6% | +1.0% | General Mills leans on mix, innovation and e-commerce amid pressure |
Latest beats and misses
Who reports nextBeat on EPS
Get the KDP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2026-07-26T00:37:55.686058+00:00
- Polygon adjusted daily market bars · 2026-10-08T03:40:41.196310+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-08T03:40:41.193464+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-08. For educational purposes only; not investment advice.